tiprankstipranks
iTeos Therapeutics Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsiTeos Therapeutics Reports Q3 2024 Financial Results
3M ago
iTeos Therapeutics reports Q3 EPS ($1.05), consensus (89c)
Premium
The Fly
iTeos Therapeutics reports Q3 EPS ($1.05), consensus (89c)
3M ago
Officina Stellare Secures €1.4 Million Satellite Contract
Premium
Company Announcements
Officina Stellare Secures €1.4 Million Satellite Contract
3M ago
iTeos Therapeutics Reports Positive Phase 2 Cancer Trial Results
PremiumCompany AnnouncementsiTeos Therapeutics Reports Positive Phase 2 Cancer Trial Results
5M ago
iTeos Therapeutics announces follow-up interim data from GALAXIES Lung-201
Premium
The Fly
iTeos Therapeutics announces follow-up interim data from GALAXIES Lung-201
5M ago
iTeos Therapeutics initiated with an Overweight at Wells Fargo
Premium
The Fly
iTeos Therapeutics initiated with an Overweight at Wells Fargo
6M ago
iTeos Therapeutics (NASDAQ:ITOS): Harnessing the Power of Immunotherapy
PremiumMarket NewsiTeos Therapeutics (NASDAQ:ITOS): Harnessing the Power of Immunotherapy
9M ago
iTeos Therapeutics price target raised to $46 from $44 at H.C. Wainwright
Premium
The Fly
iTeos Therapeutics price target raised to $46 from $44 at H.C. Wainwright
9M ago
iTeos Therapeutics to sell 1.14M shares at $17.50 in registered direct offering
Premium
The Fly
iTeos Therapeutics to sell 1.14M shares at $17.50 in registered direct offering
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100